The POST-ACS Study

Clinical trial NCT05322200 · UNKNOWN

Trial details

NCT number: NCT05322200
Sponsor: Swansea Bay University Health Board
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetes Mellitus Acute Coronary Syndrome Coronary Artery Disease

Start date: 2022-08-31
Primary completion: 2024-04-28
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.